Curcumin blocks Fusobacterium nucleatum-driven tumor progression and carcinogenesis in ESCC via inhibiting the TLR4/MYD88/TRIF/STAT3 axis
Journal of Gastroenterology · 19.08.2026
DOI: 10.1007/s00535-026-02499-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 19.08.2026. Verfasst von Mila Jin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Operation Room, The First Hospital of China Medical University, Shenyang, China. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Liaoning Provincial Applied Fundamentals Research Program, Liaoning "Xingliao Yingcai Program" Medical Masters Foundation of Liaoning Provincial Health Commission, Liaoning “Xingliao Yingcai Program” Medical Masters Foundation of Liaoning Provincial Health Commission.
Abstract (Originalsprache)
BACKGROUND: The molecular mechanisms by which the epidemiologically linked bacterium Fusobacterium nucleatum (Fn) promotes Esophageal Squamous Cell Carcinoma (ESCC) malignancy are poorly defined. Here, we identify the key signaling pathways involved. METHODS: We first established the intratumoral microbiota profile to focus on Fn's role in ESCC. Using integrated models, we then confirmed that Fn promotes tumor growth, which a cisplatin (CDDP)-induced senescence model also showed contributes to chemoresistance. Finally, by analyzing key signaling molecules, we elucidated the mechanisms by which Fn drives proliferation and treatment resistance. RESULTS: We began by observing a positive correlation between Fn enrichment and elevated TLR4/STAT3 signaling in ESCC patients. Subsequent experiments in cells and animals confirmed that this correlation functionally contributes to increased tumor aggressiveness. At the mechanistic level, Fn-derived lipopolysaccharide (LPS) acts as the key trigger, activating the TLR4/MYD88/TRIF/STAT3 axis to drive pro-inflammatory signaling and SASP, thereby leading to chemoresistance. Therapeutically, curcumin counters this by directly inhibiting Fn and blocking the pathway, thereby suppressing tumor growth, attenuating SASP, and restoring drug sensitivity. CONCLUSION: The inhibition of the Fn-activated TLR4/MYD88/TRIF/STAT3 cascade represents a key mechanism through which curcumin blocks ESCC progression, identifying it as a promising candidate for therapeutic development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Operation Room, The First Hospital of China Medical University, Shenyang, China.
- Department of Thoracic Surgery, The First Hospital of China Medical University, No. 210 Baita 1 st Street, Hunnan District, Shenyang, 110001, China.
- State Key Laboratory of Molecular Oncology, Beijing Key Laboratory of Carcinogenesis and Translational Research, The First Department of Thoracic Surgery, Peking University Cancer Hospital & Institute, Beijing, China.
- Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Medical Oncology, The First Hospital of China Medical University, No. 210 Baita 1 st Street, Hunnan District, Shenyang, 110001, China.
- Department of Medical Oncology, The First Hospital of China Medical University, No. 210 Baita 1 st Street, Hunnan District, Shenyang, 110001, China. dnli@cmu.edu.cn.
Förderung
- Liaoning Provincial Applied Fundamentals Research Program
- Liaoning "Xingliao Yingcai Program" Medical Masters Foundation of Liaoning Provincial Health Commission
- Liaoning “Xingliao Yingcai Program” Medical Masters Foundation of Liaoning Provincial Health Commission
Zitieren
APA
Jin, M., Yang, Q., Qin, J., Zhao, D., Zhang, S., Wang, Z., Chen, L., Zhao, H., Nuerbieke, T., Tian, H., Li, D., & Li, W. (2026). Curcumin blocks Fusobacterium nucleatum-driven tumor progression and carcinogenesis in ESCC via inhibiting the TLR4/MYD88/TRIF/STAT3 axis. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02499-x
Vancouver
Jin M, Yang Q, Qin J, Zhao D, Zhang S, Wang Z, et al. Curcumin blocks Fusobacterium nucleatum-driven tumor progression and carcinogenesis in ESCC via inhibiting the TLR4/MYD88/TRIF/STAT3 axis. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02499-x
BibTeX
@article{Jin2026,
author = {Jin, Mila and Yang, Qiwei and Qin, Jiaqi and Zhao, Defeng and Zhang, Senyuan and Wang, Ziyi and Chen, Liang and Zhao, Hui and Nuerbieke, Tangnuer and Tian, Huizhong and Li, Danni and Li, Wenya},
title = {Curcumin blocks Fusobacterium nucleatum-driven tumor progression and carcinogenesis in ESCC via inhibiting the TLR4/MYD88/TRIF/STAT3 axis},
journal = {Journal of Gastroenterology},
year = {2026},
doi = {10.1007/s00535-026-02499-x}
}
EUVIMED